Michael B Levy
Overview
Explore the profile of Michael B Levy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
367
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elizur A, Koren Y, Appel M, Nachshon L, Levy M, Epstein-Rigbi N, et al.
J Allergy Clin Immunol Pract
. 2025 Jan;
PMID: 39800058
Background: Data on oral immunotherapy (OIT) for hazelnut allergy is limited and its potential to cross-desensitize for other nuts is unknown. Objective: To study the efficacy and safety of hazelnut...
2.
Epstein-Rigbi N, Levy M, Nachshon L, Koren Y, Goldberg M, Elizur A
Allergy Asthma Clin Immunol
. 2024 Oct;
20(1):53.
PMID: 39402617
Background: Oral immunotherapy (OIT) has become the standard of care for children with food allergy (FA) and has substantially improved their quality of life. The effect of OIT on the...
3.
Nachshon L, Schwartz N, Levy M, Goldberg M, Epstein-Rigbi N, Katz Y, et al.
J Allergy Clin Immunol Pract
. 2024 Mar;
12(3):797-798.
PMID: 38458704
No abstract available.
4.
Goldberg M, Appel M, Tobi K, Levy M, Epstein-Rigbi N, Holmqvist M, et al.
J Allergy Clin Immunol Pract
. 2024 Feb;
12(5):1273-1282.e5.
PMID: 38382880
Background: Because of the high cross-sensitization among tree nuts, the NUT CRACKER (Nut Co-reactivity-Acquiring Knowledge for Elimination Recommendations) study proposed a diagnostic algorithm to minimize the number of required oral...
5.
Nachshon L, Westerhout J, Blom W, Remington B, Levy M, Goldberg M, et al.
Allergy
. 2023 Aug;
78(12):3212-3220.
PMID: 37606275
Background: Sesame is a significant food allergen causing severe and even fatal reactions. Given its increasing prevalence in western diet, sesame is listed as an allergenic food requiring labeling in...
6.
Nachshon L, Schwartz N, Levy M, Goldberg M, Epstein-Rigbi N, Katz Y, et al.
J Allergy Clin Immunol Pract
. 2023 Mar;
11(8):2524-2533.e3.
PMID: 36925102
Background: Severe anaphylactic reactions to home doses may occur during food allergy oral immunotherapy (OIT). Objective: To study the rate and risk factors for such reactions. Methods: We studied all...
7.
Nachshon L, Schwartz N, Levy M, Goldberg M, Epstein-Rigbi N, Katz Y, et al.
Ann Allergy Asthma Immunol
. 2022 Dec;
130(3):340-346.e5.
PMID: 36509409
Background: Home reactions requiring epinephrine administration, a marker of their severity, restrict the widespread use of oral immunotherapy (OIT), but their risk factors are largely not known. Objective: To identify...
8.
Epstein-Rigbi N, Elizur A, Levy M, Nachshon L, Koren Y, Shalem Z, et al.
J Allergy Clin Immunol Pract
. 2022 Nov;
11(4):1303-1305.e2.
PMID: 36423867
No abstract available.
9.
Epstein-Rigbi N, Levy M, Nachshon L, Koren Y, Katz Y, Goldberg M, et al.
Allergy
. 2022 Oct;
78(3):803-811.
PMID: 36190349
Background: Oral immunotherapy (OIT) is an emerging method for treating food allergy in children. However, data regarding adults undergoing this process are lacking. Methods: We retrospectively analyzed the medical records...
10.
Koren Y, Nachshon L, Goldberg M, Levy M, Epstein-Rigbi N, Elizur A
Pediatr Res
. 2022 May;
93(3):643-648.
PMID: 35641552
Background: Ascribing food allergy diagnosis to patients who are not allergic is well described, but its implications on oral immunotherapy (OIT) have not been studied. The aim was to study...